Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wagner

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cancer Medicine|November 4, 2021
Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in MississippiMegan A Clarke, Carolann Risley, Mary W Stewart, et al.
The Journal of Infectious Diseases|September 20, 2019
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus GenotypesSarah Wagner, David Roberson, Joseph Boland, et al.
Journal of the National Cancer Institute|February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT TrialSabrina H Tsang, Joshua N Sampson, John Schussler, et al.
The Lancet. Oncology|December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine TrialCarolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Lab on a Chip|October 17, 2023
A new tissue-agnostic microfluidic device to model physiology and disease: the lattice platformHannes Campo, Didi Zha, Pawat Pattarawat, et al.
BMC Cancer|May 17, 2018
Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
BMC Cancer|March 1, 2020
Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
Science Translational Medicine|October 27, 2021
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G<sub>4</sub>C<sub>2</sub>) repeat expansion in vitro and in vivo ALS modelsJessica A Bush, Haruo Aikawa, Rita Fuerst, et al.
BMC Public Health|February 12, 2024
Changes in physical activity and sedentary behavior during the first COVID-19 pandemic- restrictions in Germany: a nationwide survey : Running head: physical activity during the COVID-19 restrictionsFlorian Herbolsheimer, Annette Peters, Sarah Wagner, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer Medicine|November 4, 2021
Age-specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in MississippiMegan A Clarke, Carolann Risley, Mary W Stewart, et al.
The Journal of Infectious Diseases|September 20, 2019
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus GenotypesSarah Wagner, David Roberson, Joseph Boland, et al.
Journal of the National Cancer Institute|February 25, 2020
Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT TrialSabrina H Tsang, Joshua N Sampson, John Schussler, et al.
The Lancet. Oncology|December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine TrialCarolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
Lab on a Chip|October 17, 2023
A new tissue-agnostic microfluidic device to model physiology and disease: the lattice platformHannes Campo, Didi Zha, Pawat Pattarawat, et al.
BMC Cancer|May 17, 2018
Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
BMC Cancer|March 1, 2020
Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
Science Translational Medicine|October 27, 2021
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G<sub>4</sub>C<sub>2</sub>) repeat expansion in vitro and in vivo ALS modelsJessica A Bush, Haruo Aikawa, Rita Fuerst, et al.
BMC Public Health|February 12, 2024
Changes in physical activity and sedentary behavior during the first COVID-19 pandemic- restrictions in Germany: a nationwide survey : Running head: physical activity during the COVID-19 restrictionsFlorian Herbolsheimer, Annette Peters, Sarah Wagner, et al.
Pageof 9